CONCORD, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) — AssetMark (NYSE: AMK), a leading wealth management platform for financial advisors, today announced […]
– Progressing plans to develop ABP-450 (prabotulinumtoxinA) injection as a biosimilar utilizing BOTOX® (onabotulinumtoxinA) as the reference product – – […]